Company page

Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc. (Ticker: RYTM) is a public company based in the United States, specializing in the development of innovative therapies for rare genetic diseases related to obesity. With a market capitalization of approximately $7 billion, Rhythm focuses on addressing unmet medical needs through its research and development efforts. The company's commitment to improving patient outcomes positions it as a key player in the biotechnology sector.